|
2786
|
(±)-PH 797804
|
Inhibitor of p38α MAPK |
€115.00
|
|
1291
|
AEG 3482
|
JNK inhibitor |
€90.00
|
|
2002
|
Bentamapimod
|
JNK inhibitor, which inhibited JNK1, JNK2 and JNK3 |
€70.00
|
|
1358
|
BIRB 796
|
MAPK inhibitor (p38 specific) |
€65.00
|
|
2856
|
BMS 582949
|
Inhibitor of p38α MAPK |
€155.00
|
|
2025
|
CC-401
|
ATP-competitive JNK inhibitor |
€120.00
|
|
2634
|
CC-930
|
Potent, selective, and orally active anti-fibrotic JNK inhibitor |
€95.00
|
|
1694
|
FR 180204
|
ERK inhibitor; AP-1 inhibitor |
€95.00
|
|
3741
|
GDC-0994
|
ERK1/2 inhibitor |
Inquire
|
|
3625
|
GNE-3511
|
Potent, selective, orally bioavailable and brain-penetrant DLK inhibitor |
€90.00
|
|
2949
|
JNK inhibitor VIII
|
Selective, ATP-competitive, and cell-permeable JNK inhibitor |
€105.00
|
|
2361
|
JNK-IN-8
|
Remarkably potent and selective covalent inhibitor of JNK |
€95.00
|
|
1895
|
LY 2228820
|
Inhibitor of p38 MAPK |
€105.00
|
|
3893
|
LY-3214996
|
Orally bioavailable, potent and highly selective inhibitor of ERK1 and ERK2 |
Inquire
|
|
3620
|
MAPK13 inhibitor compound 61
|
MAPK13 inhibitor (p38δ specific) |
€140.00
|
|
3197
|
Mitochonic acid 5
|
Mitochondrial drug; Activator of MAPK-ERK-yap signalling |
€90.00
|
|
1365
|
PD169316
|
MAPK inhibitor (p38 specific) |
€95.00
|
|
1837
|
PH 797804
|
Inhibitor of p38α MAPK |
€115.00
|
|
1364
|
SB 202190
|
MAPK inhibitor (p38 specific) |
€95.00
|
|
1363
|
SB 203580
|
MAPK inhibitor (p38 specific) |
€95.00
|
|
1465
|
SB 203580 hydrochloride
|
MAPK inhibitor (p38 specific) |
€70.00
|
|
2444
|
SB 706504
|
Selective p38 MAPK inhibitor that targets a subset of inflammatory macrophage genes. |
€125.00
|
|
3867
|
SCH772984 hydrochloride
|
Potent, specific and ATP competitive inhibitor of ERK1 and ERK2 |
Inquire
|
|
3803
|
SCH900353
|
ERK1/2 inhibitor |
Inquire
|
|
1671
|
SCIO 469
|
MAPK inhibitor (p38 specific) |
€120.00
|
|
1357
|
SD 169
|
MAPK inhibitor (p38α specific) |
€60.00
|
|
2519
|
SP 600125
|
Selective, reversible, and ATP-competitive JNK inhibitor |
€70.00
|
|
2365
|
SR 3576
|
Very potent JNK3 inhibitor with >2800-fold selectivity over p38 |
€135.00
|
|
3183
|
SR-318
|
Highly potent and selective type-II p38 α/β inhibitor |
€120.00
|
|
4151
|
Ulixertinib hydrochloride
|
Potent, orally active, highly selective, ATP-competitive and reversible covalent inhibitor of ERK1/2 kinases |
Inquire
|